13 operations-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"OSU" positions in Mexico
Sort by
Refine Your Search
-
high-throughput workflows, including single-cell proteomics. It operates state-of-the-art instrumentation and advanced data analysis pipelines within the multidisciplinary ecosystem of Human Technopole
-
of the HORIZON EU-funded PRE-CVD project, working closely with the Project’s Scientific Coordinator (Dr. Zuccolo). Your mission As Scientific Project Manager you will act as the operational lead of the European
-
develop computational methods that connect human genetic variation to biological function. Using population-scale human genetics together with single-cell, spatial, and multimodal molecular data, you will
-
states, tissue organization, and biological programs, and connect these representations to mechanisms of human disease. Your work will sit at the intersection of machine learning, computational biology
-
of biological discovery. Your work will combine methodological innovation, biological discovery, and scientific software development at the intersection of artificial intelligence, computational biology, and
-
, analyte binding, environmental responsiveness) to meet device requirements. This provides a unique opportunity to iteratively couple materials design with device performance. This position offers
-
qualified candidates to join its Management Committee, the governing body responsible for the operational leadership of the Foundation. The Committee appoints Centre Directors through international selection
-
function at multiple scales. Our overarching goal is to achieve a mechanistic understanding of ciliopathies, a diverse group of human disorders characterized by heterogeneous clinical manifestations
-
role sits at the interface between software engineering, machine learning and clinical translation. The successful candidate will work closely with data scientists, computational biologists, clinicians
-
are seeking an ambitious postdoctoral researcher to establish in vitro reprogramming and differentiation systems for modelling leukaemia-immune interactions and CAR T-cell function. The successful candidate